{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T16:10:19Z","timestamp":1784218219227,"version":"3.55.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ajoc.2026.102587","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T23:44:03Z","timestamp":1776728643000},"page":"102587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Visually significant corneal deposits associated with rifabutin therapy for Bartonella henselae"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8451-054X","authenticated-orcid":false,"given":"Ailin","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa B.","family":"Daluvoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2969-1015","authenticated-orcid":false,"given":"Thomas J.","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajoc.2026.102587_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2021-000943","article-title":"Drug-induced corneal deposits: an up-to-date review","volume":"7","author":"Sahyoun","year":"2022","journal-title":"BMJ Open Ophthalmol"},{"key":"10.1016\/j.ajoc.2026.102587_bib2","article-title":"Rifabutin corneal deposits localized to the deep stroma using anterior segment optical coherence tomography","volume":"18","author":"Zhang","year":"2020","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"3","key":"10.1016\/j.ajoc.2026.102587_bib3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/112067210901900327","article-title":"Rifabutin corneal deposits in a patient with acquired immunodeficiency syndrome: in vivo confocal microscopy investigation","volume":"19","author":"Mazzotta","year":"2009","journal-title":"Eur J Ophthalmol"},{"issue":"21","key":"10.1016\/j.ajoc.2026.102587_bib4","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000020049","article-title":"Intraocular deposits and cataracts after long-term rifabutin intake","volume":"99","author":"Harada","year":"2020","journal-title":"Medicine (Baltim)"},{"issue":"2","key":"10.1016\/j.ajoc.2026.102587_bib5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0002-9394(98)00310-9","article-title":"Corneal endothelial deposits in children positive for human immunodeficiency virus receiving rifabutin prophylaxis for Mycobacterium avium complex bacteremia","volume":"127","author":"Smith","year":"1999","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajoc.2026.102587_bib6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/sj.eye.6701826","article-title":"Corneal endothelial deposits associated with rifabutin treatment in Crohn's disease","volume":"20","author":"Mitra","year":"2006","journal-title":"Eye"},{"issue":"6","key":"10.1016\/j.ajoc.2026.102587_bib7","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/bjo.87.6.798","article-title":"Corneal endothelial deposits secondary to rifabutin prophylaxis for Mycobacterium avium complex bacteraemia","volume":"87","author":"Golchin","year":"2003","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajoc.2026.102587_bib8","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/ICO.0b013e3181bd4979","article-title":"Persistent corneal endothelial deposits associated with rifabutin therapy for Crohn's disease","volume":"29","author":"Williams","year":"2010","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.ajoc.2026.102587_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0940-2993(11)80273-3","article-title":"Overview of toxicological data on rifabutin","volume":"47","author":"Brughera","year":"1995","journal-title":"Exp Toxicol Pathol"},{"issue":"7","key":"10.1016\/j.ajoc.2026.102587_bib10","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1053\/j.gastro.2007.03.031","article-title":"Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease","volume":"132","author":"Selby","year":"2007","journal-title":"Gastroenterology"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993626000757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993626000757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:47:44Z","timestamp":1784216864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993626000757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":10,"alternative-id":["S2451993626000757"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2026.102587","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Visually significant corneal deposits associated with rifabutin therapy for Bartonella henselae","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2026.102587","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102587"}}